Tranexamic acid in off-pump coronary surgery: A preliminary, randomized, double-blind, placebo-controlled study

Annals of Thoracic Surgery

Volumn 72, Issue 2, 2001, Pages 470-475

  Casati, Valter ^a   Gerli, Chiara ^a   Franco, Annalisa ^a   Torri, Giorgio ^a   D’angelo, Armando ^a   Benussi, Stefano ^a   Alfieri, Ottavio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; D DIMER; FIBRINOGEN; HEPARIN; PLACEBO; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM;

AGED; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY DISEASE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMOSTASIS, SURGICAL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PREMEDICATION; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 0034908049     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02802-8     Document Type: Article

References (20)

1. Myocardial revascularization without extracorporeal circulation: Seven-year experience in 593 cases
2. Direct myocardial revascularization without extracorporeal circulation: Experience in 700 patients
3. Off or on bypass: What is the safety threshold?
4. Systematic off-pump coronary artery revascularization in multivessel disease: Experience of three hundred cases
5. Inflammatory response to cardiopulmonary bypass
6. Hemostasis changes during cardiopulmonary bypass surgery
7. Blood product use in cardiac revascularization: Comparison of on- and off-pump techniques
8. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
9. Economic outcome of off-pump coronary artery bypass surgery: A prospective randomized study
10. Clinical application of inhibitors of fibrinolysis
11. Hemostatic effects of aprotinin, tranexamic acid and ε-aminocaproic acid in primary cardiac surgery
12. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: Effects on perioperative bleeding and allogeneic transfusions
13. Cardiac surgery and the coagulation system
14. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery
15. Procoagulant activity after off-pump coronary operation: Is the current anticoagulation adequate?
16. D-dimer formation during cardiac and non-cardiac thoracic surgery
17. Activation of coagulation and fibrinolysis during cardiothoracic operations
18. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass
19. Significance of D-dimer concentrations during and after cardiopulmonary bypass
20. The effects of ε-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery